Lung cancer tumorigenicity and drug resistance are maintained through ALDH(hi)CD44(hi) tumor initiating cells

Limited improvement in long term survival of lung cancer patients has been achieved by conventional chemotherapy or targeted therapy. To explore the potentials of tumor initiating cells (TIC)-directed therapy, it is essential to identify the cell targets and understand their maintenance mechanisms....

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jing, Xiao, Zhijie, Wong, Sunny Kit-Man, Tin, Vicky Pui-Chi, Ho, Ka-Yan, Wang, Junwen, Sham, Mai-Har, Wong, Maria Pik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2013
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3858556/
https://www.ncbi.nlm.nih.gov/pubmed/24091605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3858556/
https://www.ncbi.nlm.nih.gov/pubmed/24091605

Ejemplares similares